Modulating p38MAPK recalibrates sensitivity of drug-resistant pancreatic adenoductal carcinoma cells toward chemotherapy and correlate with improved outcome in PDAC patients: Experimental and metadata evidence
Vandana Mehra, Khushi Gandhi, Prasenjit Das, Gayatri Sharma, Monika Bhardwaj, Céline Gongora, Hridayesh Prakash
This paper shows that inhibiting p38MAPK increases sensitivity of drug-resistant pancreatic cancer cells to chemotherapy and correlates with better patient outcomes.
bioRxiv · Oct 4, 2025 · PreprintCancer Biology